Cite
HARVARD Citation
Stark, D. et al. (2017). Quality of life with cediranib in relapsed ovarian cancer: The ICON6 phase 3 randomized clinical trial. Cancer. 123 (14), pp. 2752-2761. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Stark, D. et al. (2017). Quality of life with cediranib in relapsed ovarian cancer: The ICON6 phase 3 randomized clinical trial. Cancer. 123 (14), pp. 2752-2761. [Online].